Wellnex Life Valuation Multiples

Discover Wellnex Life's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like IMD Companies, Highlander Enterprise, Nosium, Fifty 1 Labs and more.

Wellnex Life Overview

About Wellnex Life

Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group’s offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.


Founded

2011

HQ

Australia

Employees

N/A

Financials (FY)

Revenue: $16M
EBITDA: ($8M)

EV

$9M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Wellnex Life Financials

Wellnex Life reported last fiscal year revenue of $16M and negative EBITDA of ($8M).

In the same fiscal year, Wellnex Life generated $5M in gross profit, ($8M) in EBITDA losses, and had net loss of ($10M).


Wellnex Life P&L

In the most recent fiscal year, Wellnex Life reported revenue of $16M and EBITDA of ($8M).

Wellnex Life is unprofitable as of last fiscal year, with gross margin of 30%, EBITDA margin of (49%), and net margin of (62%).

See analyst estimates for Wellnex Life
Last FY202320242025202620272028
Revenue$16M$15M$14M$16M
Gross Profit$5M$3M$4M$5M
Gross Margin30%22%30%30%
EBITDA($8M)($8M)($8M)($8M)
EBITDA Margin(49%)(52%)(57%)(49%)
EBIT Margin(38%)(30%)(38%)(38%)
Net Profit($10M)($10M)($10M)($11M)
Net Margin(62%)(64%)(74%)(65%)
Net Debt$4M---

Financial data powered by Morningstar, Inc.

Wellnex Life Stock Performance

Wellnex Life has current market cap of $3M, and enterprise value of $9M.


Wellnex Life's stock price is $0.03.

Wellnex Life share price increased by 9.2% in the last 30 days.

Wellnex Life has an EPS (earnings per share) of $-0.14.

See more trading valuation data for Wellnex Life
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9M$3M0.4%9.2%--$-0.14

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Wellnex Life Valuation Multiples

Wellnex Life trades at 0.5x EV/Revenue multiple, and (1.1x) EV/EBITDA.

See NTM and 2027E valuation multiples for Wellnex Life

Wellnex Life Financial Valuation Multiples

As of July 2, 2026, Wellnex Life has market cap of $3M and EV of $9M.

Wellnex Life has a P/E ratio of (0.2x).

Last FY202320242025202620272028
EV/Revenue0.5x0.6x0.6x0.5x
EV/EBITDA(1.1x)(1.1x)(1.1x)(1.1x)
EV/EBIT(1.4x)(1.9x)(1.6x)(1.4x)
EV/Gross Profit1.8x2.6x2.1x1.8x
P/E(0.2x)(0.3x)(0.2x)(0.2x)
EV/FCF(6.5x)(1.9x)(2.9x)(6.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Wellnex Life Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Wellnex Life Margins & Growth Rates

In the most recent fiscal year, Wellnex Life reported gross margin of 30%, EBITDA margin of (49%), and net margin of (62%).

See estimated margins and future growth rates for Wellnex Life

Wellnex Life Margins

Last FY20242025202720282029
Gross Margin30%30%30%
EBITDA Margin(49%)(57%)(49%)
EBIT Margin(38%)(38%)(38%)
Net Margin(62%)(74%)(65%)
FCF Margin(8%)(22%)(8%)

Wellnex Life Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(9%)17%
Gross Profit Growth24%17%
EBITDA Growth(1%)0%
EBIT Growth15%17%
Net Profit Growth6%3%
FCF Growth(32%)(56%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Wellnex Life Operational KPIs

Access forward-looking KPIs for Wellnex Life
Last FY202320242025202620272028
S&M Expenses to Revenue11%16%14%11%
G&A Expenses to Revenue48%33%47%48%
Opex to Revenue68%52%68%68%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Wellnex Life Competitors

Wellnex Life competitors include IMD Companies, Highlander Enterprise, Nosium, Fifty 1 Labs, NxGen Brands, Emergent Health, Momentous Holdings, Nuchev, Aroma and La savonnerie de Nyons.

Most Wellnex Life public comparables operate across Health & Beauty.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
IMD Companies----
Highlander Enterprise33.9x-44.2x-
Nosium1.3x-(0.8x)-
Fifty 1 Labs7690.3x-(443.7x)-
NxGen Brands----
Emergent Health----
Momentous Holdings--(14.4x)-
Nuchev0.4x-(2.9x)-

This data is available for Pro users. Sign up to see all Wellnex Life competitors and their valuation data.

Start Free Trial

Acquisitions by Wellnex Life

Wellnex Life has acquired 1 company to date.

Last acquisition by Wellnex Life was on December 18th 2023. Wellnex Life acquired Pain Away for $14M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Wellnex Life

Pain Away
Description
Pain Away is an Australia-based manufacturer of topical pain relief products designed for joint and muscle inflammation. The company offers gels like PainAway Fast Acting Rub containing natural anti-inflammatory agents such as arnica, menthol, and boswellia, alongside adhesive patches for targeted application. These over-the-counter remedies target athletes and everyday users seeking non-drug relief, distributed through pharmacies, health stores, and online platforms across Australia.
HQ CountryAustralia
HQ City
Melbourne
Deal Date18 Dec 2023
Valuation$14M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Wellnex Life acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Wellnex Life

When was Wellnex Life founded?Wellnex Life was founded in 2011.
Where is Wellnex Life headquartered?Wellnex Life is headquartered in Australia.
Is Wellnex Life publicly listed?Yes, Wellnex Life is a public company listed on Australian Securities Exchange.
What is the stock symbol of Wellnex Life?Wellnex Life trades under WNX ticker.
When did Wellnex Life go public?Wellnex Life went public in 2017.
Who are competitors of Wellnex Life?Wellnex Life main competitors include IMD Companies, Highlander Enterprise, Nosium, Fifty 1 Labs, NxGen Brands, Emergent Health, Momentous Holdings, Nuchev, Aroma, La savonnerie de Nyons.
What is the current market cap of Wellnex Life?Wellnex Life's current market cap is $3M.
What is the current revenue of Wellnex Life?Wellnex Life's last fiscal year revenue is $16M.
What is the current EV/Revenue multiple of Wellnex Life?Current revenue multiple of Wellnex Life is 0.5x.
Is Wellnex Life profitable?No, Wellnex Life is not profitable.
How many companies Wellnex Life has acquired to date?As of July 2026, Wellnex Life has acquired 1 company.
What was the largest acquisition by Wellnex Life?$14M acquisition of Pain Away on 18th December 2023 was the largest M&A Wellnex Life has done to date.
What companies Wellnex Life acquired?Wellnex Life acquired Pain Away.
In how many companies Wellnex Life has invested to date?Wellnex Life hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Wellnex Life

Lists including Wellnex Life

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial